Reuters logo
BRIEF-Foamix Q2 loss per share $0.44
August 8, 2017 / 8:17 PM / 4 months ago

BRIEF-Foamix Q2 loss per share $0.44

Aug 8 (Reuters) - Foamix Pharmaceuticals Ltd

* Foamix reports second quarter 2017 financial results and provides business update

* Q2 loss per share $0.44

* Q2 revenue $798,000 versus $752,000

* Foamix pharmaceuticals - ‍“currently well-capitalized”, have sufficient cash to fund key development programs (FMX101 and FMX103) until mid-2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below